Upgrade to SI Premium - Free Trial

IceCure Medical Ltd (ICCM)

2.23 +0.03 (1.36%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/25/26)

Latest Headlines

Form 6-K IceCure Medical Ltd. For: Aug 24 August 24, 2026 8:15 AM - SEC Filing IceCure Medical signs Netherlands distribution deal with Scovas Medical August 24, 2026 7:50 AM - StreetInsider IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands August 24, 2026 7:50 AM - PR NewsWire West Cancer Center cleared to enroll patients in IceCure breast study August 20, 2026 8:17 AM - StreetInsider West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation August 20, 2026 8:16 AM - PR NewsWire Form EFFECT IceCure Medical Ltd. August 19, 2026 6:05 AM - SEC Filing Form EFFECT IceCure Medical Ltd. August 19, 2026 6:05 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Good Shad August 17, 2026 8:26 AM - SEC Filing Form 3 IceCure Medical Ltd. For: Aug 12 Filed by: Salton David August 17, 2026 8:18 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Tel-Tzure Tlalit Bussi August 17, 2026 8:17 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Levav Shay August 17, 2026 8:16 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Dotan Merav Nir August 17, 2026 8:16 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 14 Filed by: Peleg Meir August 17, 2026 8:16 AM - SEC Filing Form 4 IceCure Medical Ltd. For: Aug 12 Filed by: Chan Vincent Chun Hung August 17, 2026 8:15 AM - SEC Filing Form S-8 IceCure Medical Ltd. August 14, 2026 5:20 PM - SEC Filing Form 6-K IceCure Medical Ltd. For: Aug 14 August 14, 2026 4:17 PM - SEC Filing Form SCHEDULE 13G IceCure Medical Ltd. Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:16 AM - SEC Filing Form POS AM IceCure Medical Ltd. August 13, 2026 4:41 PM - SEC Filing Form POS AM IceCure Medical Ltd. August 13, 2026 4:32 PM - SEC Filing Two peer-reviewed studies examine cryoablation's role in breast cancer care August 13, 2026 9:10 AM - StreetInsider IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation August 13, 2026 9:10 AM - PR NewsWire Form 6-K IceCure Medical Ltd. For: Jun 30 August 12, 2026 8:45 AM - SEC Filing IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year August 12, 2026 8:30 AM - PR NewsWire Form 6-K IceCure Medical Ltd. For: Aug 11 August 11, 2026 4:16 PM - SEC Filing Form 6-K IceCure Medical Ltd. For: Aug 06 August 6, 2026 4:07 PM - SEC Filing IceCure Medical enrolls first patient site for breast cancer study August 6, 2026 8:05 AM - StreetInsider IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment August 6, 2026 8:05 AM - PR NewsWire IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026 August 5, 2026 8:30 AM - PR NewsWire IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense® July 29, 2026 8:25 AM - PR NewsWire IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site July 27, 2026 8:32 AM - PR NewsWire IceCure Medical expands U.S. sales team after 70% install base growth July 14, 2026 8:33 AM - StreetInsider IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation July 14, 2026 8:32 AM - PR NewsWire IceCure reports ProSense cryoablation growth in Brazil after FDA nod July 6, 2026 8:12 AM - StreetInsider IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer July 6, 2026 8:11 AM - PR NewsWire Form EFFECT IceCure Medical Ltd. July 6, 2026 6:04 AM - SEC Filing Form 6-K IceCure Medical Ltd. For: Jul 02 July 2, 2026 4:16 PM - SEC Filing Form 6-K IceCure Medical Ltd. For: Jun 26 June 26, 2026 4:30 PM - SEC Filing Form F-3 IceCure Medical Ltd. June 25, 2026 4:31 PM - SEC Filing Form D IceCure Medical Ltd. June 25, 2026 4:01 PM - SEC Filing Form 6-K IceCure Medical Ltd. For: Jun 25 June 25, 2026 8:45 AM - SEC Filing IceCure Medical regains Nasdaq minimum bid price compliance June 25, 2026 8:12 AM - StreetInsider IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement June 25, 2026 8:12 AM - PR NewsWire IceCure cites journal article on cryoablation vs. RFA for breast cancer June 23, 2026 8:11 AM - StreetInsider IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer June 23, 2026 8:10 AM - PR NewsWire Form 6-K IceCure Medical Ltd. For: Jun 18 June 18, 2026 4:47 PM - SEC Filing IceCure Medical prices $5.5 million private placement at $3.00 per share June 17, 2026 1:15 PM - StreetInsider IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor June 17, 2026 1:15 PM - PR NewsWire Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers June 17, 2026 10:38 AM - StreetInsider IceCure Medical reports 70% growth in U.S. install base for breast cryoablation June 17, 2026 8:29 AM - StreetInsider IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance June 17, 2026 8:25 AM - PR NewsWire Full Article List